Literature DB >> 4121034

Y bodies and similar fluorescent chromocentres in human tumours including teratomata.

N B Atkin.   

Abstract

The presence of Y bodies and similar fluorescent chromocentres in the interphase cells of 73 benign and malignant neoplastic lesions of males, and 69 of females, has been assessed in preparations stained with quinacrine dihydrochloride. In the male, Y bodies were usually present, although none was seen in 16 of the 65 malignant tumours. Sometimes the Y body was present in duplicate, for example, in some regions of a benign polyp of the colon and generally in 10 of the malignant tumours. The series includes 5 seminomata and 12 malignant testicular teratomata, all of which were positive for Y bodies.The tumours of females failed to show similar bodies, with 5 exceptions: one of 13 carcinomata of the ovary showed a body resembling the Y body in about half the cells (however, a similar body was seen in lymphocytes from this case) while a further carcinoma of probable ovarian origin, and 3 of 13 ovarian dermoids, showed a similar body though in less than 20% of the cells.Although quinacrine fluorescence studies on interphase tumour cells may be of value in suggesting the presence or absence of Y chromosomes, it is desirable that these studies be supplemented by the investigation of the fluorescence pattern of the metaphase chromosomes.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4121034      PMCID: PMC2008842          DOI: 10.1038/bjc.1973.22

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells.

Authors:  H E Skipper; F M Schabel; W S Wilcox
Journal:  Cancer Chemother Rep       Date:  1967-06

2.  Technique for identifying Y chromosomes in human interphase nuclei.

Authors:  P L Pearson; M Bobrow; C G Vosa
Journal:  Nature       Date:  1970-04-04       Impact factor: 49.962

3.  Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice.

Authors:  E Mihich
Journal:  Cancer Res       Date:  1969-04       Impact factor: 12.701

4.  Immunogenicity of L 1210 murine leukaemia cells after treatment with neuraminidase.

Authors:  K D Bagshawe; G A Currie
Journal:  Nature       Date:  1968-06-29       Impact factor: 49.962

5.  An alteration in tumor histocompatibility induced by neuraminidase.

Authors:  B H Sanford
Journal:  Transplantation       Date:  1967-09-05       Impact factor: 4.939

6.  Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXI.

Authors:  J Leiter; B J Abbott; S A Schepartz
Journal:  Can Res Suppl       Date:  1964-12

7.  Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.

Authors:  G A Currie; K D Bagshawe
Journal:  Br J Cancer       Date:  1969-03       Impact factor: 7.640

8.  The effect of neuraminidase on the fate of transfused lymphocytes.

Authors:  J J Woodruff; B M Gesner
Journal:  J Exp Med       Date:  1969-03-01       Impact factor: 14.307

9.  The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumour.

Authors:  G A Currie; K D Bagshawe
Journal:  Br J Cancer       Date:  1968-12       Impact factor: 7.640

10.  Triple sex chromatin, and other sex chromatin anomalies, in tumours of females.

Authors:  N B Atkin
Journal:  Br J Cancer       Date:  1967-03       Impact factor: 7.640

View more
  1 in total

1.  Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma.

Authors:  C O'Toole; Z H Price; Y Ohnuki; B Unsgaard
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.